Study of asciminib in adults with Ph+ CML on Scemblix
Treatments studied
Part of Blood & lymphatic, Cancer clinical trials.
This trial looks at using asciminib in people with Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML) who are taking Scemblix. If you already use Scemblix, the study may test whether switching or adding asciminib is safe and helpful for managing your leukemia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re an adult (18 or older) with Ph+ chronic myeloid leukemia (CML)
- You are currently taking, or will soon take, Scemblix according to your local approved label
- You agree to sign written informed consent before joining the study
- You do not have any Scemblix-related contraindication (a medical reason you can’t take it) listed in your local label
- You will not take any investigational (research) medicines during the observation period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a targeted pill called asciminib for people newly diagnosed with chronic-phase CML. It aims to see if this drug is safe and effective as an early treatment option.
This study looks at how safe and effective asciminib is for young adults with chronic myeloid leukemia (CML) in the Gulf region. It uses existing medical records to gather information, so no extra visits are needed.
This study looks at how well asciminib works in real-world patients with chronic myeloid leukemia who have already tried at least one other treatment. It aims to see how effective and safe it is in everyday practice.
This trial tests the drug asciminib for people newly diagnosed with chronic myeloid leukemia (CML) who have been on treatment for less than a month. It aims to see if early treatment with asciminib is safe and effective.
This study looks at how well the medicine Scemblix (asciminib) works for people in China who have just been diagnosed with a certain type of leukemia (chronic myeloid leukemia in chronic phase). It aims to see if starting this treatment soon after diagnosis is effective and safe.
This trial tests an oral medication called asciminib in children and teens with a type of leukemia called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). It aims to see if the drug is safe and effective for patients who are newly diagnosed or whose current treatment has stopped working or caused side effects.
Hear when a new Chronic Myeloid Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.